Skip to main content
PMC home page
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1997 Apr;10(2):220–241. doi: 10.1128/cmr.10.2.220

Enterobacter spp.: pathogens poised to flourish at the turn of the century.

W E Sanders Jr 1, C C Sanders 1
PMCID: PMC172917  PMID: 9105752

Abstract

Knowledge of the genus Enterobacter and its role in human disease has expanded exponentially in recent years. The incidence of infection in the hospital and the community has increased. New clinical syndromes have been recognized. Enterobacter spp. have also been implicated as causes of other syndromes that traditionally have been associated almost exclusively with more easily treatable pathogens, such as group A streptococci and staphylococci. Rapid emergence of multiple-drug resistance has been documented in individual patients during therapy and in populations and environments with strong selective pressure from antimicrobial agents, especially the cephalosporins. Therapeutic options for patients infected with multiply resistant strains have become severely limited. Carbapenems or, alternatively, fluoroquinolones are the most predictively active options, although resistance to both classes has been observed on rare occasions. Enterobacter spp. appear well adapted for survival and even proliferation as the turn of the century approaches.

Full Text

The Full Text of this article is available as a PDF (243.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alford R. H., Hall A. Epidemiology of infections caused by gentamicin-resistant enterobacteriaceae and Pseudomonas aeruginosa over 15 years at the Nashville Veterans Administration Medical Center. Rev Infect Dis. 1987 Nov-Dec;9(6):1079–1086. doi: 10.1093/clinids/9.6.1079. [DOI] [PubMed] [Google Scholar]
  2. Alvarez C., Hunt K., Ashley S. W., Reber H. A. Emphysematous cholecystitis after ERCP. Dig Dis Sci. 1994 Aug;39(8):1719–1723. doi: 10.1007/BF02087783. [DOI] [PubMed] [Google Scholar]
  3. Andersen B. M., Almdahl S. M., Sørlie D., Hotvedt R., Backer-Christensen J., Nicolaysen R. B., Solem O. I. Enterobacter cloacae-infeksjoner ved Regionsykehuset i Tromsø. Tidsskr Nor Laegeforen. 1990 Jan 30;110(3):342–347. [PubMed] [Google Scholar]
  4. Anderson E. L., Hieber J. P. An outbreak of gentamicin-resistant Enterobacter cloacae infections in a pediatric intensive care unit. Infect Control. 1983 May-Jun;4(3):148–152. doi: 10.1017/s0195941700058069. [DOI] [PubMed] [Google Scholar]
  5. Andresen J., Asmar B. I., Dajani A. S. Increasing Enterobacter bacteremia in pediatric patients. Pediatr Infect Dis J. 1994 Sep;13(9):787–792. doi: 10.1097/00006454-199409000-00007. [DOI] [PubMed] [Google Scholar]
  6. Armstrong R. W., Bolding F., Joseph R. Septic arthritis following arthroscopy: clinical syndromes and analysis of risk factors. Arthroscopy. 1992;8(2):213–223. doi: 10.1016/0749-8063(92)90039-e. [DOI] [PubMed] [Google Scholar]
  7. Aubert G., Levy P. P., Ros A., Meley R., Meley B., Bourge A., Dorche G. Changes in the sensitivity of urinary pathogens to quinolones between 1987 and 1990 in France. Eur J Clin Microbiol Infect Dis. 1992 May;11(5):475–477. doi: 10.1007/BF01961870. [DOI] [PubMed] [Google Scholar]
  8. Ballow C. H., Schentag J. J. Trends in antibiotic utilization and bacterial resistance. Report of the National Nosocomial Resistance Surveillance Group. Diagn Microbiol Infect Dis. 1992 Feb;15(2 Suppl):37S–42S. [PubMed] [Google Scholar]
  9. Bamberger D. M., Dahl S. L. Impact of voluntary vs enforced compliance of third-generation cephalosporin use in a teaching hospital. Arch Intern Med. 1992 Mar;152(3):554–557. [PubMed] [Google Scholar]
  10. Baquero F. Pneumococcal resistance to beta-lactam antibiotics: a global geographic overview. Microb Drug Resist. 1995 Summer;1(2):115–120. doi: 10.1089/mdr.1995.1.115. [DOI] [PubMed] [Google Scholar]
  11. Barry A. L., Fuchs P. C., Pfaller M. A., Allen S. D., Gerlach E. H. Prevalence of fluoroquinolone-resistant bacterial isolates in four medical centers during the first quarter of 1990. Eur J Clin Microbiol Infect Dis. 1990 Dec;9(12):906–908. doi: 10.1007/BF01967511. [DOI] [PubMed] [Google Scholar]
  12. Bauernfeind A., Jungwirth R., Schweighart S. In-vitro activity of meropenem imipenem, the penem HRE 664 and ceftazidine against clinical isolates from West Germany. J Antimicrob Chemother. 1989 Sep;24 (Suppl A):73–84. doi: 10.1093/jac/24.suppl_a.73. [DOI] [PubMed] [Google Scholar]
  13. Bellon J., Mouton R. P. Distribution of beta lactamases in Enterobacteriaceae: indoor versus outdoor strains. Chemotherapy. 1992;38(2):77–81. doi: 10.1159/000238945. [DOI] [PubMed] [Google Scholar]
  14. Ben Redjeb S., Fournier G., Philippon A., Ben Yaghlane H., Labia R., Boujnah A. Prevalence of resistance phenotypes to beta-lactam antibiotics among 4800 isolates of Enterobacteriaceae and distribution of beta-lactamases. J Chemother. 1989 Jul;1(4 Suppl):336–338. [PubMed] [Google Scholar]
  15. Bennett S. N., McNeil M. M., Bland L. A., Arduino M. J., Villarino M. E., Perrotta D. M., Burwen D. R., Welbel S. F., Pegues D. A., Stroud L. Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N Engl J Med. 1995 Jul 20;333(3):147–154. doi: 10.1056/NEJM199507203330303. [DOI] [PubMed] [Google Scholar]
  16. Binfiglio G., Stefani S., Nicoletti G. In vitro activity of cefpirome against beta-lactamase-inducible and stably derepressed Enterobacteriaceae. Chemotherapy. 1994 Sep-Oct;40(5):311–316. doi: 10.1159/000239212. [DOI] [PubMed] [Google Scholar]
  17. Bingen E., Denamur E., Lambert-Zechovsky N., Brahimi N., el Lakany M., Elion J. Rapid genotyping shows the absence of cross-contamination in Enterobacter cloacae nosocomial infections. J Hosp Infect. 1992 Jun;21(2):95–101. doi: 10.1016/0195-6701(92)90028-k. [DOI] [PubMed] [Google Scholar]
  18. Bittner M. J., Dworzack D. L., Preheim L. C., Tofte R. W., Crossley K. B. Ceftriaxone therapy of serious bacterial infections in adults. Antimicrob Agents Chemother. 1983 Feb;23(2):261–266. doi: 10.1128/aac.23.2.261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Bodey G. P., Elting L. S., Rodriguez S. Bacteremia caused by Enterobacter: 15 years of experience in a cancer hospital. Rev Infect Dis. 1991 Jul-Aug;13(4):550–558. doi: 10.1093/clinids/13.4.550. [DOI] [PubMed] [Google Scholar]
  20. Bonadio W. A., Margolis D., Tovar M. Enterobacter cloacae bacteremia in children: a review of 30 cases in 12 years. Clin Pediatr (Phila) 1991 May;30(5):310–313. doi: 10.1177/000992289103000509. [DOI] [PubMed] [Google Scholar]
  21. Bone R. C. Gram-negative sepsis: a dilemma of modern medicine. Clin Microbiol Rev. 1993 Jan;6(1):57–68. doi: 10.1128/cmr.6.1.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Bonten M. J., Gaillard C. A., van Tiel F. H., Smeets H. G., van der Geest S., Stobberingh E. E. The stomach is not a source for colonization of the upper respiratory tract and pneumonia in ICU patients. Chest. 1994 Mar;105(3):878–884. doi: 10.1378/chest.105.3.878. [DOI] [PubMed] [Google Scholar]
  23. Bouza E., García de la Torre M., Erice A., Loza E., Diaz-Borrego J. M., Buzón L. Enterobacter bacteremia. An analysis of 50 episodes. Arch Intern Med. 1985 Jun;145(6):1024–1027. doi: 10.1001/archinte.145.6.1024. [DOI] [PubMed] [Google Scholar]
  24. Breyer S., Feistauer S. M., Burgmann H., Georgopoulos M., Georgopoulos A. Epidemiologie und Erregerspektrum der Harnwegsinfektionen. Wien Med Wochenschr. 1991;141(23-24):533–536. [PubMed] [Google Scholar]
  25. Bruckner D. A., Colonna P. Nomenclature for aerobic and facultative bacteria. Clin Infect Dis. 1995 Aug;21(2):263–272. doi: 10.1093/clinids/21.2.263. [DOI] [PubMed] [Google Scholar]
  26. Bryan C. S., John J. F., Jr, Pai M. S., Austin T. L. Gentamicin vs cefotaxime for therapy of neonatal sepsis. Relationship to drug resistance. Am J Dis Child. 1985 Nov;139(11):1086–1089. doi: 10.1001/archpedi.1985.02140130024022. [DOI] [PubMed] [Google Scholar]
  27. Buchholz D. H., Young V. M., Friedman N. R., Reilly J. A., Mardiney M. R., Jr Bacterial proliferation in platelet products stored at room temperature. Transfusion-induced Enterobacter sepsis. N Engl J Med. 1971 Aug 19;285(8):429–433. doi: 10.1056/NEJM197108192850803. [DOI] [PubMed] [Google Scholar]
  28. Burchard K. W., Barrall D. T., Reed M., Slotman G. J. Enterobacter bacteremia in surgical patients. Surgery. 1986 Nov;100(5):857–862. [PubMed] [Google Scholar]
  29. Burwen D. R., Banerjee S. N., Gaynes R. P. Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. National Nosocomial Infections Surveillance System. J Infect Dis. 1994 Dec;170(6):1622–1625. doi: 10.1093/infdis/170.6.1622. [DOI] [PubMed] [Google Scholar]
  30. Bush K., Jacoby G. A., Medeiros A. A. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother. 1995 Jun;39(6):1211–1233. doi: 10.1128/aac.39.6.1211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Carsenti-Etesse H., Durant J., De Salvador F., Bensoussan M., Bensoussan F., Pradier C., Thabaut A., Dellamonica P. In vitro development of resistance of Streptococcus pneumoniae to beta-lactam antibiotics. Microb Drug Resist. 1995 Spring;1(1):85–94. doi: 10.1089/mdr.1995.1.85. [DOI] [PubMed] [Google Scholar]
  32. Chamberland S., L'Ecuyer J., Lessard C., Bernier M., Provencher P., Bergeron M. G. Antibiotic susceptibility profiles of 941 gram-negative bacteria isolated from septicemic patients throughout Canada. The Canadian Study Group. Clin Infect Dis. 1992 Oct;15(4):615–628. doi: 10.1093/clind/15.4.615. [DOI] [PubMed] [Google Scholar]
  33. Chassagne P., Mejjad O., Daragon A., Lecomte R., Le Loet X., Deshayes P. Spondylodiscite à Enterobacter cloacae traitée par le céfixime. Presse Med. 1990 Apr 7;19(14):673–674. [PubMed] [Google Scholar]
  34. Chenoweth C., Schaberg D. The epidemiology of enterococci. Eur J Clin Microbiol Infect Dis. 1990 Feb;9(2):80–89. doi: 10.1007/BF01963631. [DOI] [PubMed] [Google Scholar]
  35. Chow J. W., Fine M. J., Shlaes D. M., Quinn J. P., Hooper D. C., Johnson M. P., Ramphal R., Wagener M. M., Miyashiro D. K., Yu V. L. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med. 1991 Oct 15;115(8):585–590. doi: 10.7326/0003-4819-115-8-585. [DOI] [PubMed] [Google Scholar]
  36. Chow J. W., Yu V. L., Shlaes D. M. Epidemiologic perspectives on Enterobacter for the infection control professional. Am J Infect Control. 1994 Aug;22(4):195–201. doi: 10.1016/0196-6553(94)90067-1. [DOI] [PubMed] [Google Scholar]
  37. Chumbley L. C. Canaliculitis caused by Enterobacter cloacae: report of a case. Br J Ophthalmol. 1984 May;68(5):364–366. doi: 10.1136/bjo.68.5.364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Chung K. I., Lim T. H., Koh Y. S., Song J. H., Kim W. S., Choi J. M., Auh Y. H. Nosocomial pneumonia in medico-surgical intensive care unit. J Korean Med Sci. 1992 Sep;7(3):241–251. doi: 10.3346/jkms.1992.7.3.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Cohen S. P., Yan W., Levy S. B. A multidrug resistance regulatory chromosomal locus is widespread among enteric bacteria. J Infect Dis. 1993 Aug;168(2):484–488. doi: 10.1093/infdis/168.2.484. [DOI] [PubMed] [Google Scholar]
  40. Conus P., Francioli P. Relationship between ceftriaxone use and resistance of Enterobacter species. J Clin Pharm Ther. 1992 Oct;17(5):303–305. doi: 10.1111/j.1365-2710.1992.tb01308.x. [DOI] [PubMed] [Google Scholar]
  41. Daw M. A., Corcoran G. D., Falkiner F. R., Keane C. T. Application and assessment of cloacin typing of Enterobacter cloacae. J Hosp Infect. 1992 Mar;20(3):141–151. doi: 10.1016/0195-6701(92)90082-w. [DOI] [PubMed] [Google Scholar]
  42. De Champs C., Sauvant M. P., Chanal C., Sirot D., Gazuy N., Malhuret R., Baguet J. C., Sirot J. Prospective survey of colonization and infection caused by expanded-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae in an intensive care unit. J Clin Microbiol. 1989 Dec;27(12):2887–2890. doi: 10.1128/jcm.27.12.2887-2890.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Deguchi K., Yokota N., Koguchi M., Nakane Y., Fukayama S., Ishihara R., Oda S., Tanaka S., Sato K., Fukumoto T. [Antimicrobial activities of gentamicin against fresh clinical isolates]. Jpn J Antibiot. 1990 Oct;43(10):1674–1684. [PubMed] [Google Scholar]
  44. Deusch E., End A., Grimm M., Graninger W., Klepetko W., Wolner E. Early bacterial infections in lung transplant recipients. Chest. 1993 Nov;104(5):1412–1416. doi: 10.1378/chest.104.5.1412. [DOI] [PubMed] [Google Scholar]
  45. Deutsch D. H., Miller S. F., Finley R. K., Jr The use of intestinal antibiotics to delay or prevent infections in patients with burns. J Burn Care Rehabil. 1990 Sep-Oct;11(5):436–442. doi: 10.1097/00004630-199009000-00011. [DOI] [PubMed] [Google Scholar]
  46. Dornbusch K., Miller G. H., Hare R. S., Shaw K. J. Resistance to aminoglycoside antibiotics in gram-negative bacilli and staphylococci isolated from blood. Report from a European collaborative study. The ESGAR Study Group (European Study Group on Antibiotic Resistance). J Antimicrob Chemother. 1990 Jul;26(1):131–144. doi: 10.1093/jac/26.1.131. [DOI] [PubMed] [Google Scholar]
  47. Edwards J. R. Meropenem: a microbiological overview. J Antimicrob Chemother. 1995 Jul;36 (Suppl A):1–17. doi: 10.1093/jac/36.suppl_a.1. [DOI] [PubMed] [Google Scholar]
  48. Ehni W. F., Reller L. B., Ellison R. T., 3rd Bacteremia in granulocytopenic patients in a tertiary-care general hospital. Rev Infect Dis. 1991 Jul-Aug;13(4):613–619. doi: 10.1093/clinids/13.4.613. [DOI] [PubMed] [Google Scholar]
  49. Ehrhardt A. F., Sanders C. C., Thomson K. S., Watanakunakorn C., Trujillano-Martin I. Emergence of resistance to imipenem in Enterobacter isolates masquerading as Klebsiella pneumoniae during therapy with imipenem/cilastatin. Clin Infect Dis. 1993 Jul;17(1):120–122. doi: 10.1093/clinids/17.1.120. [DOI] [PubMed] [Google Scholar]
  50. Ehrhardt A. F., Sanders C. C. beta-Lactam resistance amongst Enterobacter species. J Antimicrob Chemother. 1993 Nov;32 (Suppl B):1–11. doi: 10.1093/jac/32.suppl_b.1. [DOI] [PubMed] [Google Scholar]
  51. Eltahawy A. T., Mokhtar A. A., Khalaf R. M., Bahnassy A. A. Postoperative wound infection at a university hospital in Jeddah, Saudi Arabia. J Hosp Infect. 1992 May;21(1):79–83. doi: 10.1016/0195-6701(92)90156-g. [DOI] [PubMed] [Google Scholar]
  52. Falkiner F. R. Enterobacter in hospital. J Hosp Infect. 1992 Mar;20(3):137–140. doi: 10.1016/0195-6701(92)90081-v. [DOI] [PubMed] [Google Scholar]
  53. Farmer J. J., 3rd, Davis B. R., Hickman-Brenner F. W., McWhorter A., Huntley-Carter G. P., Asbury M. A., Riddle C., Wathen-Grady H. G., Elias C., Fanning G. R. Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimens. J Clin Microbiol. 1985 Jan;21(1):46–76. doi: 10.1128/jcm.21.1.46-76.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Ferguson R., Feeney C., Chirurgi V. A. Enterobacter agglomerans--associated cotton fever. Arch Intern Med. 1993 Oct 25;153(20):2381–2382. [PubMed] [Google Scholar]
  55. Finegold S. M., Johnson C. C. Lower respiratory tract infection. Am J Med. 1985 Nov 29;79(5B):73–77. doi: 10.1016/0002-9343(85)90132-9. [DOI] [PubMed] [Google Scholar]
  56. Flaherty J. P., Garcia-Houchins S., Chudy R., Arnow P. M. An outbreak of gram-negative bacteremia traced to contaminated O-rings in reprocessed dialyzers. Ann Intern Med. 1993 Dec 1;119(11):1072–1078. doi: 10.7326/0003-4819-119-11-199312010-00003. [DOI] [PubMed] [Google Scholar]
  57. Flynn D. M., Weinstein R. A., Nathan C., Gaston M. A., Kabins S. A. Patients' endogenous flora as the source of "nosocomial" Enterobacter in cardiac surgery. J Infect Dis. 1987 Aug;156(2):363–368. doi: 10.1093/infdis/156.2.363. [DOI] [PubMed] [Google Scholar]
  58. Forsgren A., Walder M. Antimicrobial susceptibility of bacterial isolates in south Sweden including a 13-year follow-up study of some respiratory tract pathogens. APMIS. 1994 Mar;102(3):227–235. doi: 10.1111/j.1699-0463.1994.tb04869.x. [DOI] [PubMed] [Google Scholar]
  59. Fryklund B. A., Tullus K., Burman L. G. Association between climate and Enterobacter colonization in Swedish neonatal units. Infect Control Hosp Epidemiol. 1993 Oct;14(10):579–582. doi: 10.1086/646641. [DOI] [PubMed] [Google Scholar]
  60. Fuchs P. C., Barry A. L., Jones R. N. In vitro activity and disk susceptibility of Timentin: current status. Am J Med. 1985 Nov 29;79(5B):25–32. doi: 10.1016/0002-9343(85)90125-1. [DOI] [PubMed] [Google Scholar]
  61. Fuchs P. C., Jones R. N., Barry A. L., Thornsberry C. Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin. Antimicrob Agents Chemother. 1985 May;27(5):679–682. doi: 10.1128/aac.27.5.679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Fung C. P., Wang L. S., Juang Y. C., Liu C. Y., Cheng D. L. Enterobacter cloacae bacteremia: clinical analysis of 41 cases. Zhonghua Yi Xue Za Zhi (Taipei) 1988 Oct;42(4):297–304. [PubMed] [Google Scholar]
  63. Galili D., Donitza A., Garfunkel A., Sela M. N. Gram-negative enteric bacteria in the oral cavity of leukemia patients. Oral Surg Oral Med Oral Pathol. 1992 Oct;74(4):459–462. doi: 10.1016/0030-4220(92)90295-2. [DOI] [PubMed] [Google Scholar]
  64. Gallagher P. G., Ball W. S. Cerebral infarctions due to CNS infection with Enterobacter sakazakii. Pediatr Radiol. 1991;21(2):135–136. doi: 10.1007/BF02015629. [DOI] [PubMed] [Google Scholar]
  65. Gallagher P. G. Enterobacter bacteremia in pediatric patients. Rev Infect Dis. 1990 Sep-Oct;12(5):808–812. doi: 10.1093/clinids/12.5.808. [DOI] [PubMed] [Google Scholar]
  66. Ganelin R. S., Ellis M. Cellulitis caused by Enterobacter cloacae. J Infect. 1992 Mar;24(2):218–219. doi: 10.1016/0163-4453(92)93214-b. [DOI] [PubMed] [Google Scholar]
  67. García-Rodríguez J. A., García Sánchez J. E., Muñoz Bellido J. L., García García M. I. Current status of bacterial resistance to third-generation cephalosporins. Diagn Microbiol Infect Dis. 1992 Jan;15(1):67–72. doi: 10.1016/0732-8893(92)90058-2. [DOI] [PubMed] [Google Scholar]
  68. Gaston M. A. Enterobacter: an emerging nosocomial pathogen. J Hosp Infect. 1988 Apr;11(3):197–208. doi: 10.1016/0195-6701(88)90098-9. [DOI] [PubMed] [Google Scholar]
  69. Geerdes H. F., Ziegler D., Lode H., Hund M., Loehr A., Fangmann W., Wagner J. Septicemia in 980 patients at a university hospital in Berlin: prospective studies during 4 selected years between 1979 and 1989. Clin Infect Dis. 1992 Dec;15(6):991–1002. doi: 10.1093/clind/15.6.991. [DOI] [PubMed] [Google Scholar]
  70. George R. C., Ball L. C., Norbury P. B. Susceptibility to ciprofloxacin of nosocomial gram-negative bacteria and staphylococci isolated in the UK. J Antimicrob Chemother. 1990 Dec;26 (Suppl F):145–156. doi: 10.1093/jac/26.suppl_f.145. [DOI] [PubMed] [Google Scholar]
  71. Georghiou P. R., Hamill R. J., Wright C. E., Versalovic J., Koeuth T., Watson D. A., Lupski J. R. Molecular epidemiology of infections due to Enterobacter aerogenes: identification of hospital outbreak-associated strains by molecular techniques. Clin Infect Dis. 1995 Jan;20(1):84–94. doi: 10.1093/clinids/20.1.84. [DOI] [PubMed] [Google Scholar]
  72. Gerding D. N., Larson T. A., Hughes R. A., Weiler M., Shanholtzer C., Peterson L. R. Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital. Antimicrob Agents Chemother. 1991 Jul;35(7):1284–1290. doi: 10.1128/aac.35.7.1284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Giamarellou H., Koratzanis G., Kanellakopoulou K., Daikos G. K. Epidemiological study of Enterobacter cloacae resistant to 3rd generation cephalosporins: a preliminary report. Chemioterapia. 1985 Feb;4(1):43–46. [PubMed] [Google Scholar]
  74. Goepp J. G., Lee C. K., Anderson T., Dick J. D., Stokoe J. M., Eiden J. Use of ciprofloxacin in an infant with ventriculitis. J Pediatr. 1992 Aug;121(2):303–305. doi: 10.1016/s0022-3476(05)81210-7. [DOI] [PubMed] [Google Scholar]
  75. Goldstein F. W., Péan Y., Rosato A., Gertner J., Gutmann L. Characterization of ceftriaxone-resistant Enterobacteriaceae: a multicentre study in 26 French hospitals. Vigil'Roc Study Group. J Antimicrob Chemother. 1993 Oct;32(4):595–603. doi: 10.1093/jac/32.4.595. [DOI] [PubMed] [Google Scholar]
  76. Greenberg R. N., Bowne D. B., Gelfand M., Sathe S. S. Multicenter in vitro comparison of piperacillin and nine other antibacterials against 1,629 clinical isolates. Clin Ther. 1990 Jan-Feb;12(1):61–70. [PubMed] [Google Scholar]
  77. Grier J. F., Cohen S. W., Grafton W. D., Gholson C. F. Acute suppurative cholangitis associated with choledochal sludge. Am J Gastroenterol. 1994 Apr;89(4):617–619. [PubMed] [Google Scholar]
  78. Grüneberg R. N. Changes in urinary pathogens and their antibiotic sensitivities, 1971-1992. J Antimicrob Chemother. 1994 May;33 (Suppl A):1–8. doi: 10.1093/jac/33.suppl_a.1. [DOI] [PubMed] [Google Scholar]
  79. Gürses N., Ozkan A. Neonatal and childhood purpura fulminans: review of seven cases. Cutis. 1988 May;41(5):361–363. [PubMed] [Google Scholar]
  80. Haddy R. I., Cecil M. L., Norris L. L., Markert R. J. Enterobacter bacteremia in the community hospital. J Fam Pract. 1991 Jun;32(6):601–606. [PubMed] [Google Scholar]
  81. Haertl R., Bandlow G. Molecular typing of Enterobacter cloacae by pulsed-field gel electrophoresis of genomic restriction fragments. J Hosp Infect. 1993 Oct;25(2):109–116. doi: 10.1016/0195-6701(93)90101-5. [DOI] [PubMed] [Google Scholar]
  82. Harabe E., Kawai Y., Kanazawa K., Otsuki M., Nishino T. In vitro and in vivo antibacterial activities of meropenem, a new carbapenem antibiotic. Drugs Exp Clin Res. 1992;18(2):37–46. [PubMed] [Google Scholar]
  83. Haug J. B., Harthug S., Kalager T., Digranes A., Solberg C. O. Bloodstream infections at a Norwegian university hospital, 1974-1979 and 1988-1989: changing etiology, clinical features, and outcome. Clin Infect Dis. 1994 Aug;19(2):246–256. doi: 10.1093/clinids/19.2.246. [DOI] [PubMed] [Google Scholar]
  84. Hawkins R. E., Lissner C. R., Sanford J. P. Enterobacter sakazakii bacteremia in an adult. South Med J. 1991 Jun;84(6):793–795. doi: 10.1097/00007611-199106000-00033. [DOI] [PubMed] [Google Scholar]
  85. Helovuo H., Forssell K., Hakkarainen K. Oral mucosal soft tissue necrosis caused by superinfection. Report of three cases. Oral Surg Oral Med Oral Pathol. 1991 May;71(5):543–548. doi: 10.1016/0030-4220(91)90358-j. [DOI] [PubMed] [Google Scholar]
  86. Helovuo H., Hakkarainen K., Paunio K. Changes in the prevalence of subgingival enteric rods, staphylococci and yeasts after treatment with penicillin and erythromycin. Oral Microbiol Immunol. 1993 Apr;8(2):75–79. doi: 10.1111/j.1399-302x.1993.tb00548.x. [DOI] [PubMed] [Google Scholar]
  87. Heusser M. F., Patterson J. E., Kuritza A. P., Edberg S. C., Baltimore R. S. Emergence of resistance to multiple beta-lactams in Enterobacter cloacae during treatment for neonatal meningitis with cefotaxime. Pediatr Infect Dis J. 1990 Jul;9(7):509–512. doi: 10.1097/00006454-199007000-00011. [DOI] [PubMed] [Google Scholar]
  88. Hibbert-Rogers L. C., Heritage J., Gascoyne-Binzi D. M., Hawkey P. M., Todd N., Lewis I. J., Bailey C. Molecular epidemiology of ceftazidime resistant Enterobacteriaceae from patients on a paediatric oncology ward. J Antimicrob Chemother. 1995 Jul;36(1):65–82. doi: 10.1093/jac/36.1.65. [DOI] [PubMed] [Google Scholar]
  89. Hoban D. J., Jones R. N., Harrell L. J., Knudson M., Sewell D. The North American component (the United States and Canada) of an International Comparative MIC trial monitoring ofloxacin resistance. Diagn Microbiol Infect Dis. 1993 Aug-Sep;17(2):157–161. doi: 10.1016/0732-8893(93)90027-5. [DOI] [PubMed] [Google Scholar]
  90. Hopkins J. M., Towner K. J. Enhanced resistance to cefotaxime and imipenem associated with outer membrane protein alterations in Enterobacter aerogenes. J Antimicrob Chemother. 1990 Jan;25(1):49–55. doi: 10.1093/jac/25.1.49. [DOI] [PubMed] [Google Scholar]
  91. Huovinen S., Klossner M. L., Katila M. L., Huovinen P. Plasmid-mediated beta-lactamases among aminoglycoside resistant gram-negative bacilli. Scand J Infect Dis. 1989;21(3):303–309. doi: 10.3109/00365548909035700. [DOI] [PubMed] [Google Scholar]
  92. Iannini P. B., Hull S. F., Quintiliani R. Severe sepsis from Enterobacter. Arch Surg. 1973 Dec;107(6):854–856. doi: 10.1001/archsurg.1973.01350240024008. [DOI] [PubMed] [Google Scholar]
  93. Irvine W. D., Flynn H. W., Jr, Miller D., Pflugfelder S. C. Endophthalmitis caused by gram-negative organisms. Arch Ophthalmol. 1992 Oct;110(10):1450–1454. doi: 10.1001/archopht.1992.01080220112031. [DOI] [PubMed] [Google Scholar]
  94. Jacobson K. L., Cohen S. H., Inciardi J. F., King J. H., Lippert W. E., Iglesias T., VanCouwenberghe C. J. The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I beta-lactamase-producing organisms. Clin Infect Dis. 1995 Nov;21(5):1107–1113. doi: 10.1093/clinids/21.5.1107. [DOI] [PubMed] [Google Scholar]
  95. Jarvis W. R., Martone W. J. Predominant pathogens in hospital infections. J Antimicrob Chemother. 1992 Apr;29 (Suppl A):19–24. doi: 10.1093/jac/29.suppl_a.19. [DOI] [PubMed] [Google Scholar]
  96. Jarvis W. R., White J. W., Munn V. P., Mosser J. L., Emori T. G., Culver D. H., Thornsberry C., Hughes J. M. Nosocomial infection surveillance, 1983. MMWR CDC Surveill Summ. 1984;33(2):9SS–21SS. [PubMed] [Google Scholar]
  97. John J. F., Jr, Sharbaugh R. J., Bannister E. R. Enterobacter cloacae: bacteremia, epidemiology, and antibiotic resistance. Rev Infect Dis. 1982 Jan-Feb;4(1):13–28. doi: 10.1093/clinids/4.1.13. [DOI] [PubMed] [Google Scholar]
  98. Johnson M. P., Ramphal R. Beta-lactam-resistant Enterobacter bacteremia in febrile neutropenic patients receiving monotherapy. J Infect Dis. 1990 Oct;162(4):981–983. doi: 10.1093/infdis/162.4.981. [DOI] [PubMed] [Google Scholar]
  99. Jones R. N., Barrett M. S., Erwin M. E. In-vitro activity of FK-037, a new parenteral cephalosporin. J Antimicrob Chemother. 1994 Jan;33(1):137–144. doi: 10.1093/jac/33.1.137. [DOI] [PubMed] [Google Scholar]
  100. Jones R. N., Barry A. L., Thornsberry C. In-vitro studies of meropenem. J Antimicrob Chemother. 1989 Sep;24 (Suppl A):9–29. doi: 10.1093/jac/24.suppl_a.9. [DOI] [PubMed] [Google Scholar]
  101. Jones R. N., Erwin M. E., Barrett M. S., Johnson D. M., Briggs B. M. Antimicrobial activity of E-1040, a novel thiadiazolyl cephalosporin compared with other parenteral cephems. Diagn Microbiol Infect Dis. 1991 Jul-Aug;14(4):301–309. doi: 10.1016/0732-8893(91)90021-7. [DOI] [PubMed] [Google Scholar]
  102. Jones R. N. Fluoroquinolone resistance. An evolving national problem or just a problem for some physicians? Diagn Microbiol Infect Dis. 1992 Feb;15(2):177–179. doi: 10.1016/0732-8893(92)90046-v. [DOI] [PubMed] [Google Scholar]
  103. Jones R. N., Pfaller M. A., Fuchs P. C., Aldridge K., Allen S. D., Gerlach E. H. Piperacillin/tazobactam (YTR 830) combination. Comparative antimicrobial activity against 5889 recent aerobic clinical isolates and 60 Bacteroides fragilis group strains. Diagn Microbiol Infect Dis. 1989 Nov-Dec;12(6):489–494. [PubMed] [Google Scholar]
  104. Jones R. N. The antimicrobial activity of cefotaxime: comparative multinational hospital isolate surveys covering 15 years. Infection. 1994;22 (Suppl 3):S152–S160. doi: 10.1007/BF01782700. [DOI] [PubMed] [Google Scholar]
  105. Jones R. N. The current and future impact of antimicrobial resistance among nosocomial bacterial pathogens. Diagn Microbiol Infect Dis. 1992 Feb;15(2 Suppl):3S–10S. [PubMed] [Google Scholar]
  106. Kappstein I., Schulgen G., Friedrich T., Hellinger P., Benzing A., Geiger K., Daschner F. D. Incidence of pneumonia in mechanically ventilated patients treated with sucralfate or cimetidine as prophylaxis for stress bleeding: bacterial colonization of the stomach. Am J Med. 1991 Aug 8;91(2A):125S–131S. doi: 10.1016/0002-9343(91)90464-9. [DOI] [PubMed] [Google Scholar]
  107. Karnad A., Alvarez S., Berk S. L. Enterobacter pneumonia. South Med J. 1987 May;80(5):601–604. doi: 10.1097/00007611-198705000-00013. [DOI] [PubMed] [Google Scholar]
  108. King A., Boothman C., Phillips I. Comparative in vitro activity of cefpirome and cefepime, two new cephalosporins. Eur J Clin Microbiol Infect Dis. 1990 Sep;9(9):677–685. doi: 10.1007/BF01964272. [DOI] [PubMed] [Google Scholar]
  109. King A., Boothman C., Phillips I. Comparative in-vitro activity of meropenem on clinical isolates from the United Kingdom. J Antimicrob Chemother. 1989 Sep;24 (Suppl A):31–45. doi: 10.1093/jac/24.suppl_a.31. [DOI] [PubMed] [Google Scholar]
  110. Kjølen H., Andersen B. M. Handwashing and disinfection of heavily contaminated hands--effective or ineffective? J Hosp Infect. 1992 May;21(1):61–71. doi: 10.1016/0195-6701(92)90154-e. [DOI] [PubMed] [Google Scholar]
  111. Kosakai N., Kumamoto Y., Hirose T., Tanaka N., Hikichi Y., Shigeta S., Shiraiwa Y., Kameoka H., Yoshida H., Ogata M. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1988). III. Secular changes in susceptibility]. Jpn J Antibiot. 1992 Sep;45(9):1112–1237. [PubMed] [Google Scholar]
  112. Kresken M., Jansen A., Wiedemann B. Prevalence of resistance of aerobic gram-negative bacilli to broad-spectrum antibacterial agents: results of a multicentre study. J Antimicrob Chemother. 1990 Jun;25(6):1022–1024. doi: 10.1093/jac/25.6.1022. [DOI] [PubMed] [Google Scholar]
  113. Kronish J. W., McLeish W. M. Eyelid necrosis and periorbital necrotizing fasciitis. Report of a case and review of the literature. Ophthalmology. 1991 Jan;98(1):92–98. doi: 10.1016/s0161-6420(91)32334-0. [DOI] [PubMed] [Google Scholar]
  114. Kühn I., Ayling-Smith B., Tullus K., Burman L. G. The use of colonization rate and epidemic index as tools to illustrate the epidemiology of faecal Enterobacteriaceae strains in Swedish neonatal wards. J Hosp Infect. 1993 Apr;23(4):287–297. doi: 10.1016/0195-6701(93)90146-q. [DOI] [PubMed] [Google Scholar]
  115. Kühn I., Tullus K., Burman L. G. The use of the PhP-KE biochemical fingerprinting system in epidemiological studies of faecal Enterobacter cloacae strains from infants in Swedish neonatal wards. Epidemiol Infect. 1991 Oct;107(2):311–319. doi: 10.1017/s0950268800048950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Landry P., Kamm W., Bille J., Berger J. P. Sensibilités aux antibiotiques des bactéries isolées dans le laboratoire d'un petit hôpital comparées à celles d'un grand hôpital. Rev Med Suisse Romande. 1991 Feb;111(2):151–156. [PubMed] [Google Scholar]
  117. Lee E. H., Collatz E., Trias J., Gutmann L. Diffusion of beta-lactam antibiotics into proteoliposomes reconstituted with outer membranes of isogenic imipenem-susceptible and -resistant strains of Enterobacter cloacae. J Gen Microbiol. 1992 Nov;138(11):2347–2351. doi: 10.1099/00221287-138-11-2347. [DOI] [PubMed] [Google Scholar]
  118. Lee E. H., Nicolas M. H., Kitzis M. D., Pialoux G., Collatz E., Gutmann L. Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem. Antimicrob Agents Chemother. 1991 Jun;35(6):1093–1098. doi: 10.1128/aac.35.6.1093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Leibovici L., Konisberger H., Pitlik S. D., Samra Z., Drucker M. Bacteremia and fungemia of unknown origin in adults. Clin Infect Dis. 1992 Feb;14(2):436–443. doi: 10.1093/clinids/14.2.436. [DOI] [PubMed] [Google Scholar]
  120. Leibovici L., Wysenbeek A. J., Konisberger H., Samra Z., Pitlik S. D., Drucker M. Patterns of multiple resistance to antibiotics in gram-negative bacteria demonstrated by factor analysis. Eur J Clin Microbiol Infect Dis. 1992 Sep;11(9):782–788. doi: 10.1007/BF01960876. [DOI] [PubMed] [Google Scholar]
  121. Lerner A. M. The gram-negative bacillary pneumonias. Dis Mon. 1980 Nov;27(2):1–56. doi: 10.1016/s0011-5029(80)80015-0. [DOI] [PubMed] [Google Scholar]
  122. Leying H., Cullmann W., Dick W. Carbapenem resistance in Enterobacter aerogenes is due to lipopolysaccharide alterations. Chemotherapy. 1991;37(2):106–113. doi: 10.1159/000238841. [DOI] [PubMed] [Google Scholar]
  123. Lindh E., Dornbusch K., Jalakas K., Forsgren A. Antibiotic susceptibility and beta-lactamase production in clinical isolates of Enterobacter spp. APMIS. 1990 May;98(5):462–470. [PubMed] [Google Scholar]
  124. Lindh E., Kjaeldgaard P., Frederiksen W., Ursing J. Phenotypical properties of Enterobacter agglomerans (Pantoea agglomerans) from human, animal and plant sources. APMIS. 1991 Apr;99(4):347–352. doi: 10.1111/j.1699-0463.1991.tb05160.x. [DOI] [PubMed] [Google Scholar]
  125. Lindh E., Ursing J. Genomic groups and biochemical profiles of clinical isolates of Enterobacter cloacae. APMIS. 1991 Jun;99(6):507–514. doi: 10.1111/j.1699-0463.1991.tb05183.x. [DOI] [PubMed] [Google Scholar]
  126. Liu P. Y., Gur D., Hall L. M., Livermore D. M. Survey of the prevalence of beta-lactamases amongst 1000 gram-negative bacilli isolated consecutively at the Royal London Hospital. J Antimicrob Chemother. 1992 Oct;30(4):429–447. doi: 10.1093/jac/30.4.429. [DOI] [PubMed] [Google Scholar]
  127. Livingston W., Grossman M. E., Garvey G. Hemorrhagic bullae in association with Enterobacter cloacae septicemia. J Am Acad Dermatol. 1992 Oct;27(4):637–638. doi: 10.1016/s0190-9622(08)80208-3. [DOI] [PubMed] [Google Scholar]
  128. Loessner M. J., Neugirg E., Zink R., Scherer S. Isolation, classification and molecular characterization of bacteriophages for Enterobacter species. J Gen Microbiol. 1993 Nov;139(11):2627–2633. doi: 10.1099/00221287-139-11-2627. [DOI] [PubMed] [Google Scholar]
  129. Lovering A. M., Bywater M. J., Holt H. A., Champion H. M., Reeves D. S. Resistance of bacterial pathogens to four aminoglycosides and six other antibacterials and prevalence of aminoglycoside modifying enzymes, in 20 UK centres. J Antimicrob Chemother. 1988 Dec;22(6):823–839. doi: 10.1093/jac/22.6.823. [DOI] [PubMed] [Google Scholar]
  130. Low D. E., Kaiser L. R., Haydock D. A., Trulock E., Cooper J. D. The donor lung: infectious and pathologic factors affecting outcome in lung transplantation. J Thorac Cardiovasc Surg. 1993 Oct;106(4):614–621. [PubMed] [Google Scholar]
  131. Maes P., Vanhoof R. A 56-month prospective surveillance study on the epidemiology of aminoglycoside resistance in a Belgian general hospital. Scand J Infect Dis. 1992;24(4):495–501. doi: 10.3109/00365549209052636. [DOI] [PubMed] [Google Scholar]
  132. Mani S., Edberg S. C., Patterson J. E. Community-acquired bacteremia due to multiresistant Enterobacter in a patient with urosepsis. Clin Infect Dis. 1992 Sep;15(3):565–566. doi: 10.1093/clind/15.3.565. [DOI] [PubMed] [Google Scholar]
  133. Marce S., Antoine J. F., Schaeverbeke T., Vernhes J. P., Bannwarth B., Dehais J. Enterobacter cloacae vertebral infection in a heroin addict with HIV infection. Ann Rheum Dis. 1993 Sep;52(9):695–695. doi: 10.1136/ard.52.9.695-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  134. Mascellino M. T., Iona E., Farinelli S., Iegri F., Marandola M., Pennacchiotti M. L., Cascioli C., Visco Comandini U., De Logu G. Plasmids as epidemiologic markers in nosocomial gram-negative bacilli: experience in an intensive care unit. Drugs Exp Clin Res. 1992;18(4):121–128. [PubMed] [Google Scholar]
  135. Massie J. B., Heller J. G., Abitbol J. J., McPherson D., Garfin S. R. Postoperative posterior spinal wound infections. Clin Orthop Relat Res. 1992 Nov;(284):99–108. [PubMed] [Google Scholar]
  136. Matsaniotis N. S., Syriopoulou V. P., Theodoridou M. C., Tzanetou K. G., Mostrou G. I. Enterobacter sepsis in infants and children due to contaminated intravenous fluids. Infect Control. 1984 Oct;5(10):471–477. doi: 10.1017/s0195941700060872. [DOI] [PubMed] [Google Scholar]
  137. Mayhall C. G., Lamb V. A., Gayle W. E., Jr, Haynes B. W., Jr Enterobacter cloacae septicemia in a burn center: epidemiology and control of an outbreak. J Infect Dis. 1979 Feb;139(2):166–171. doi: 10.1093/infdis/139.2.166. [DOI] [PubMed] [Google Scholar]
  138. McConkey S. J., Coleman D. C., Falkiner F. R., McCann S. R., Daly P. A. Enterobacter cloacae in a haematology/oncology ward--first impressions. J Hosp Infect. 1989 Nov;14(4):277–284. doi: 10.1016/0195-6701(89)90067-4. [DOI] [PubMed] [Google Scholar]
  139. McCown R. B. Deep infection of the hand. Kans Med. 1988 Jul;89(7):189–190. [PubMed] [Google Scholar]
  140. McGowan J. E., Jr Changing etiology of nosocomial bacteremia and fungemia and other hospital-acquired infections. Rev Infect Dis. 1985 Jul-Aug;7 (Suppl 3):S357–S370. doi: 10.1093/clinids/7.supplement_3.s357. [DOI] [PubMed] [Google Scholar]
  141. Meis J. F., Groot-Loonen J., Hoogkamp-Korstanje J. A. A brain abscess due to multiply-resistant Enterobacter cloacae successfully treated with meropenem. Clin Infect Dis. 1995 Jun;20(6):1567–1567. doi: 10.1093/clinids/20.6.1567. [DOI] [PubMed] [Google Scholar]
  142. Meyers H. B., Fontanilla E., Mascola L. Risk factors for development of sepsis in a hospital outbreak of Enterobacter aerogenes. Am J Infect Control. 1988 Jun;16(3):118–122. doi: 10.1016/0196-6553(88)90050-8. [DOI] [PubMed] [Google Scholar]
  143. Milewski S. A., Klevjer-Anderson P. Endophthalmitis caused by Enterobacter cloacae. Ann Ophthalmol. 1993 Aug;25(8):309–311. [PubMed] [Google Scholar]
  144. Mirza G. E., Karakük S., Doğanay M., Cağlayangil A. Postoperative endophthalmitis caused by an Enterobacter species. J Hosp Infect. 1994 Mar;26(3):167–172. doi: 10.1016/0195-6701(94)90039-6. [DOI] [PubMed] [Google Scholar]
  145. Modi N., Damjanovic V., Cooke R. W. Outbreak of cephalosporin resistant Enterobacter cloacae infection in a neonatal intensive care unit. Arch Dis Child. 1987 Feb;62(2):148–151. doi: 10.1136/adc.62.2.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  146. Mulgrave L. The changing ecology of hospital bacteria and the selective role of cephalosporins. Epidemiol Infect. 1991 Feb;106(1):121–132. doi: 10.1017/s095026880005648x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Murray P. R., Cantrell H. F., Lankford R. B. Multicenter evaluation of the in vitro activity of piperacillin-tazobactam compared with eleven selected beta-lactam antibiotics and ciprofloxacin against more than 42,000 aerobic gram-positive and gram-negative bacteria. In Vitro Susceptibility Surveillance Group. Diagn Microbiol Infect Dis. 1994 Jun;19(2):111–120. doi: 10.1016/0732-8893(94)90121-x. [DOI] [PubMed] [Google Scholar]
  148. Muytjens H. L., Kollée L. A. Enterobacter sakazakii meningitis in neonates: causative role of formula? Pediatr Infect Dis J. 1990 May;9(5):372–373. doi: 10.1097/00006454-199005000-00016. [DOI] [PubMed] [Google Scholar]
  149. Muytjens H. L., van der Ros-van de Repe J. Comparative in vitro susceptibilities of eight Enterobacter species, with special reference to Enterobacter sakazakii. Antimicrob Agents Chemother. 1986 Feb;29(2):367–370. doi: 10.1128/aac.29.2.367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  150. Neu H. C., Chin N. X., Jules K., Labthavikul P. The activity of BMY 28142 a new broad spectrum beta-lactamase stable cephalosporin. J Antimicrob Chemother. 1986 Apr;17(4):441–452. doi: 10.1093/jac/17.4.441. [DOI] [PubMed] [Google Scholar]
  151. Neu H. C., Chin N. X., Novelli A. In vitro activity of E-1040, a novel cephalosporin with potent activity against Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1988 Nov;32(11):1666–1675. doi: 10.1128/aac.32.11.1666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  152. Nordmann P., Mariotte S., Naas T., Labia R., Nicolas M. H. Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli. Antimicrob Agents Chemother. 1993 May;37(5):939–946. doi: 10.1128/aac.37.5.939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  153. Noriega F. R., Kotloff K. L., Martin M. A., Schwalbe R. S. Nosocomial bacteremia caused by Enterobacter sakazakiki and Leuconostoc mesenteroides resulting from extrinsic contamination of infant formula. Pediatr Infect Dis J. 1990 Jun;9(6):447–449. [PubMed] [Google Scholar]
  154. Palmer D. L., Kuritsky J. N., Lapham S. C., King R. M., Akl B. F. Enterobacter mediastinitis following cardiac surgery. Infect Control. 1985 Mar;6(3):115–119. doi: 10.1017/s0195941700062780. [DOI] [PubMed] [Google Scholar]
  155. Pareja A., Bernal C., Leyva A., Piedrola G., Maroto M. C. Etiologic study of patients with community-acquired pneumonia. Chest. 1992 May;101(5):1207–1210. doi: 10.1378/chest.101.5.1207. [DOI] [PubMed] [Google Scholar]
  156. Pariente D. Gas gangrene in a pediatric liver transplant due to infection by Enterobacter cloacae. Pediatr Radiol. 1993;23(4):331–331. [PubMed] [Google Scholar]
  157. Pechère J. C. Why are carbapenems active against Enterobacter cloacae resistant to third generation cephalosporins? Scand J Infect Dis Suppl. 1991;78:17–21. [PubMed] [Google Scholar]
  158. Peyret M., Albertini M. T., Olleon M., Davenas C., Blanc V. Détection des phénotypes de résistance des entérobactéries aux aminosides avec le système expert ATB Plus Expert. Pathol Biol (Paris) 1993 Apr;41(4):329–336. [PubMed] [Google Scholar]
  159. Peña C., Pujol M., Pallarés R., Cisnal M., Ariza J., Gudiol F. Bacteriemia nosocomial por Enterobacter spp.: epidemiología y factores pronósticos. Enferm Infecc Microbiol Clin. 1993 Oct;11(8):424–428. [PubMed] [Google Scholar]
  160. Phillips I., King A., Gransden W. R., Eykyn S. J. The antibiotic sensitivity of bacteria isolated from the blood of patients in St Thomas' Hospital, 1969-1988. J Antimicrob Chemother. 1990 Apr;25 (Suppl 100):59–80. doi: 10.1093/jac/25.suppl_c.59. [DOI] [PubMed] [Google Scholar]
  161. Piddock L. J., Griggs D. J. Selection and characterization of cefepime-resistant gram-negative bacteria. J Antimicrob Chemother. 1991 Nov;28(5):669–676. doi: 10.1093/jac/28.5.669. [DOI] [PubMed] [Google Scholar]
  162. Pitout J. D., Moland E. S., Sanders C. C., Thomson K. S., Fitzsimmons S. R. Beta-lactamases and detection of beta-lactam resistance in Enterobacter spp. Antimicrob Agents Chemother. 1997 Jan;41(1):35–39. doi: 10.1128/aac.41.1.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  163. Pittet D., Tarara D., Wenzel R. P. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1994 May 25;271(20):1598–1601. doi: 10.1001/jama.271.20.1598. [DOI] [PubMed] [Google Scholar]
  164. Prevot M. H., Andremont A., Sancho-Garnier H., Tancrede C. Epidemiology of intestinal colonization by members of the family Enterobacteriaceae resistant to cefotaxime in a hematology-oncology unit. Antimicrob Agents Chemother. 1986 Dec;30(6):945–947. doi: 10.1128/aac.30.6.945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  165. Quinn J. P., DiVincenzo C. A., Foster J. Emergence of resistance to ceftazidime during therapy for Enterobacter cloacae infections. J Infect Dis. 1987 May;155(5):942–947. doi: 10.1093/infdis/155.5.942. [DOI] [PubMed] [Google Scholar]
  166. Rajan R. K. Spontaneous bacterial peritonitis with ecthyma gangrenosum due to Escherichia coli. J Clin Gastroenterol. 1982 Apr;4(2):145–148. doi: 10.1097/00004836-198204000-00010. [DOI] [PubMed] [Google Scholar]
  167. Riain U. N., Cormican M. G., Flynn J., Smith T., Glennon M. PCR based fingerprinting of Enterobacter cloacae. J Hosp Infect. 1994 Jul;27(3):237–240. doi: 10.1016/0195-6701(94)90131-7. [DOI] [PubMed] [Google Scholar]
  168. Rice L. B., Willey S. H., Papanicolaou G. A., Medeiros A. A., Eliopoulos G. M., Moellering R. C., Jr, Jacoby G. A. Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother. 1990 Nov;34(11):2193–2199. doi: 10.1128/aac.34.11.2193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  169. Rolston K. V., Alvarez M. E., Hsu K. C., Bodey G. P. In-vitro activity of cefpirome (HR-810), WIN-49375, BMY-28142 and other antibiotics against nosocomially important isolates from cancer patients. J Antimicrob Chemother. 1986 Apr;17(4):453–457. doi: 10.1093/jac/17.4.453. [DOI] [PubMed] [Google Scholar]
  170. Rubinstien E. M., Klevjer-Anderson P., Smith C. A., Drouin M. T., Patterson J. E. Enterobacter taylorae, a new opportunistic pathogen: report of four cases. J Clin Microbiol. 1993 Feb;31(2):249–254. doi: 10.1128/jcm.31.2.249-254.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  171. Rubio M. C., Gil J., Castillo J., Otal I., Gómez-Lus M. L., Rubio E., Sarraseca C., Torrellas A., Gómez-Lus R. The susceptibility to amoxycillin/clavulanate of Enterobacteriaceae with plasmid-mediated ampicillin resistance: a twelve-year study of strains in one Spanish hospital. J Antimicrob Chemother. 1989 Nov;24 (Suppl B):35–40. doi: 10.1093/jac/24.suppl_b.35. [DOI] [PubMed] [Google Scholar]
  172. Rylander R., Lundholm M. Bacterial contamination of cotton and cotton dust and effects on the lung. Br J Ind Med. 1978 Aug;35(3):204–207. doi: 10.1136/oem.35.3.204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  173. Rylander R. The role of endotoxin for reactions after exposure to cotton dust. Am J Ind Med. 1987;12(6):687–697. doi: 10.1002/ajim.4700120607. [DOI] [PubMed] [Google Scholar]
  174. Sanders C. C. Cefepime: the next generation? Clin Infect Dis. 1993 Sep;17(3):369–379. [PubMed] [Google Scholar]
  175. Sanders C. C. Chromosomal cephalosporinases responsible for multiple resistance to newer beta-lactam antibiotics. Annu Rev Microbiol. 1987;41:573–593. doi: 10.1146/annurev.mi.41.100187.003041. [DOI] [PubMed] [Google Scholar]
  176. Sanders C. C., Sanders W. E., Jr beta-Lactam resistance in gram-negative bacteria: global trends and clinical impact. Clin Infect Dis. 1992 Nov;15(5):824–839. doi: 10.1093/clind/15.5.824. [DOI] [PubMed] [Google Scholar]
  177. Sanders C. C. beta-Lactamases of gram-negative bacteria: new challenges for new drugs. Clin Infect Dis. 1992 May;14(5):1089–1099. doi: 10.1093/clinids/14.5.1089. [DOI] [PubMed] [Google Scholar]
  178. Schaberg D. R., Culver D. H., Gaynes R. P. Major trends in the microbial etiology of nosocomial infection. Am J Med. 1991 Sep 16;91(3B):72S–75S. doi: 10.1016/0002-9343(91)90346-y. [DOI] [PubMed] [Google Scholar]
  179. Scheider D. M., King P. D., Miedema B. W. Ascites and secondary bacterial peritonitis associated with small bowel obstruction. Am J Gastroenterol. 1994 Aug;89(8):1238–1240. [PubMed] [Google Scholar]
  180. Schito G. C., Sanna A., Chezzi C., Ravizzola G., Leone F., Molinari G., Menozzi M. G., Pirali F. In-vitro activity of meropenem against clinical isolates in a multicentre study in Italy. J Antimicrob Chemother. 1989 Sep;24 (Suppl A):57–72. doi: 10.1093/jac/24.suppl_a.57. [DOI] [PubMed] [Google Scholar]
  181. Schønheyder H. C., Jensen K. T., Frederiksen W. Taxonomic notes: synonymy of Enterobacter cancerogenus (Urosević 1966) Dickey and Zumoff 1988 and Enterobacter taylorae Farmer et al. 1985 and resolution of an ambiguity in the biochemical profile. Int J Syst Bacteriol. 1994 Jul;44(3):586–587. doi: 10.1099/00207713-44-3-586. [DOI] [PubMed] [Google Scholar]
  182. Shanahan P. M., Wylie B. A., Adrian P. V., Koornhof H. J., Thomson C. J., Amyes S. G. The prevalence of antimicrobial resistance in human faecal flora in South Africa. Epidemiol Infect. 1993 Oct;111(2):221–228. doi: 10.1017/s0950268800056922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  183. Snydman D. R. Clinical implications of multi-drug resistance in the intensive care unit. Scand J Infect Dis Suppl. 1991;78:54–63. [PubMed] [Google Scholar]
  184. Solans R., Simeon P., Cuenca R., Fonollosa V., Bago J., Vilardell M. Infectious discitis caused by Enterobacter cloacae. Ann Rheum Dis. 1992 Jul;51(7):906–907. doi: 10.1136/ard.51.7.906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  185. Spiliopoulou I., Droukopoulou A., Athanassiadou A., Dimitracopoulos G. Plasmid profiles of Acinetobacter and Enterobacter species of hospital origin: restriction endonuclease analysis of plasmid DNA and transformation of Escherichia coli by R plasmids. J Chemother. 1992 Apr;4(2):72–77. doi: 10.1080/1120009x.1992.11739143. [DOI] [PubMed] [Google Scholar]
  186. Srámová H., Daniel M., Absolonová V., Dedicová D., Jedlicková Z., Lhotová H., Petrás P., Subertová V. Epidemiological role of arthropods detectable in health facilities. J Hosp Infect. 1992 Apr;20(4):281–292. doi: 10.1016/0195-6701(92)90006-8. [DOI] [PubMed] [Google Scholar]
  187. Steffee C. H., Wasilauskas B. L. Beta-lactamase expression and cross-resistance to beta-lactam antibiotics in a nosocomial population of Enterobacter. Chemotherapy. 1992;38(5):291–296. doi: 10.1159/000239016. [DOI] [PubMed] [Google Scholar]
  188. Struelens M. J., Rost F., Deplano A., Maas A., Schwam V., Serruys E., Cremer M. Pseudomonas aeruginosa and Enterobacteriaceae bacteremia after biliary endoscopy: an outbreak investigation using DNA macrorestriction analysis. Am J Med. 1993 Nov;95(5):489–498. doi: 10.1016/0002-9343(93)90331-i. [DOI] [PubMed] [Google Scholar]
  189. Taylor G. D., Kirkland T., Lakey J., Rajotte R., Warnock G. L. Bacteremia due to transplantation of contaminated cryopreserved pancreatic islets. Cell Transplant. 1994 Jan-Feb;3(1):103–106. doi: 10.1177/096368979400300114. [DOI] [PubMed] [Google Scholar]
  190. Thomas A., Lalitha M. K., Jesudason M. V., John S. Transducer related Enterobacter cloacae sepsis in post-operative cardiothoracic patients. J Hosp Infect. 1993 Nov;25(3):211–214. doi: 10.1016/0195-6701(93)90040-7. [DOI] [PubMed] [Google Scholar]
  191. Thomson B. D. Medical complications following intravenous heroin. Ariz Med. 1975 Oct;32(10):798–801. [PubMed] [Google Scholar]
  192. Thomson K. S., Sanders W. E., Sanders C. C. USA resistance patterns among UTI pathogens. J Antimicrob Chemother. 1994 May;33 (Suppl A):9–15. doi: 10.1093/jac/33.suppl_a.9. [DOI] [PubMed] [Google Scholar]
  193. Thornsberry C., Brown S. D., Yee Y. C., Bouchillon S. K., Marler J. K., Rich T. In-vitro activity of cefepime and other antimicrobials: survey of European isolates. J Antimicrob Chemother. 1993 Nov;32 (Suppl B):31–53. doi: 10.1093/jac/32.suppl_b.31. [DOI] [PubMed] [Google Scholar]
  194. Toala P., Lee Y. H., Wilcox C., Finland M. Susceptibility of Enterobacter aerogenes and Enterobacter cloacae to 19 antimicrobial agents in vitro. Am J Med Sci. 1970 Jul;260(1):41–55. [PubMed] [Google Scholar]
  195. Toye B. W., Scriver S. R., Low D. E. Canadian survey of antimicrobial resistance in Klebsiella spp. and Enterobacter spp. The Canadian Antimicrobial Resistance Study Group. J Antimicrob Chemother. 1993 Nov;32 (Suppl B):81–86. doi: 10.1093/jac/32.suppl_b.81. [DOI] [PubMed] [Google Scholar]
  196. Tsakris A., Johnson A. P., George R. C., Mehtar S., Vatopoulos A. C. Distribution and transferability of plasmids encoding trimethoprim resistance in urinary pathogens from Greece. J Med Microbiol. 1991 Mar;34(3):153–157. doi: 10.1099/00222615-34-3-153. [DOI] [PubMed] [Google Scholar]
  197. Tunkel A. R., Fisch M. J., Schlein A., Scheld W. M. Enterobacter endocarditis. Scand J Infect Dis. 1992;24(2):233–240. doi: 10.3109/00365549209052618. [DOI] [PubMed] [Google Scholar]
  198. Twum-Danso K., Grant C., al-Suleiman S. A., Abdel-Khader S., al-Awami M. S., al-Breiki H., Taha S., Ashoor A. A., Wosornu L. Microbiology of postoperative wound infection: a prospective study of 1770 wounds. J Hosp Infect. 1992 May;21(1):29–37. doi: 10.1016/0195-6701(92)90151-b. [DOI] [PubMed] [Google Scholar]
  199. Tzelepi E., Tzouvelekis L. S., Vatopoulos A. C., Mentis A. F., Tsakris A., Legakis N. J. High prevalence of stably derepressed class-I beta-lactamase expression in multiresistant clinical isolates of Enterobacter cloacae from Greek hospitals. J Med Microbiol. 1992 Aug;37(2):91–95. doi: 10.1099/00222615-37-2-91. [DOI] [PubMed] [Google Scholar]
  200. Tzouvelekis L. S., Tzelepi E., Kaufmann M. E., Mentis A. F. Consecutive mutations leading to the emergence in vivo of imipenem resistance in a clinical strain of Enterobacter aerogenes. J Med Microbiol. 1994 Jun;40(6):403–407. doi: 10.1099/00222615-40-6-403. [DOI] [PubMed] [Google Scholar]
  201. Unhanand M., Mustafa M. M., McCracken G. H., Jr, Nelson J. D. Gram-negative enteric bacillary meningitis: a twenty-one-year experience. J Pediatr. 1993 Jan;122(1):15–21. doi: 10.1016/s0022-3476(05)83480-8. [DOI] [PubMed] [Google Scholar]
  202. Uzun O., Akalin H. E., Hayran M., Unal S. Factors influencing prognosis in bacteremia due to gram-negative organisms: evaluation of 448 episodes in a Turkish university hospital. Clin Infect Dis. 1992 Nov;15(5):866–873. doi: 10.1093/clind/15.5.866. [DOI] [PubMed] [Google Scholar]
  203. Varaldo P. E., Biavasco F., Mannelli S., Pompei R., Proietti A. Distribution and antibiotic susceptibility of extraintestinal clinical isolates of Klebsiella, Enterobacter and Serratia species. Eur J Clin Microbiol Infect Dis. 1988 Aug;7(4):495–500. doi: 10.1007/BF01962599. [DOI] [PubMed] [Google Scholar]
  204. Verbist L. Epidemiology and sensitivity of 8625 ICU and hematology/oncology bacterial isolates in Europe. International Study Group. Scand J Infect Dis Suppl. 1993;91:14–24. [PubMed] [Google Scholar]
  205. Vázquez F., Mendoza M. C., Villar M. H., Pérez F., Méndez F. J. Survey of bacteraemia in a Spanish hospital over a decade (1981-1990). J Hosp Infect. 1994 Feb;26(2):111–121. doi: 10.1016/0195-6701(94)90053-1. [DOI] [PubMed] [Google Scholar]
  206. Wade J. J., Desai N., Casewell M. W. Hygienic hand disinfection for the removal of epidemic vancomycin-resistant Enterococcus faecium and gentamicin-resistant Enterobacter cloacae. J Hosp Infect. 1991 Jul;18(3):211–218. doi: 10.1016/0195-6701(91)90145-x. [DOI] [PubMed] [Google Scholar]
  207. Wagener M. M., Yu V. L. Bacteremia in transplant recipients: a prospective study of demographics, etiologic agents, risk factors, and outcomes. Am J Infect Control. 1992 Oct;20(5):239–247. doi: 10.1016/s0196-6553(05)80197-x. [DOI] [PubMed] [Google Scholar]
  208. Wagner S. J., Friedman L. I., Dodd R. Y. Transfusion-associated bacterial sepsis. Clin Microbiol Rev. 1994 Jul;7(3):290–302. doi: 10.1128/cmr.7.3.290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  209. Wang C. C., Chu M. L., Ho L. J., Hwang R. C. Analysis of plasmid pattern in paediatric intensive care unit outbreaks of nosocomial infection due to Enterobacter cloacae. J Hosp Infect. 1991 Sep;19(1):33–40. doi: 10.1016/0195-6701(91)90126-s. [DOI] [PubMed] [Google Scholar]
  210. Washington J. A., 2nd, Knapp C. C., Sanders C. C. Accuracy of microdilution and the AutoMicrobic System in detection of beta-lactam resistance in gram-negative bacterial mutants with derepressed beta-lactamase. Rev Infect Dis. 1988 Jul-Aug;10(4):824–829. doi: 10.1093/clinids/10.4.824. [DOI] [PubMed] [Google Scholar]
  211. Watanakunakorn C., Weber J. Enterobacter bacteremia: a review of 58 episodes. Scand J Infect Dis. 1989;21(1):1–8. doi: 10.3109/00365548909035673. [DOI] [PubMed] [Google Scholar]
  212. Weber D. A., Sanders C. C. Diverse potential of beta-lactamase inhibitors to induce class I enzymes. Antimicrob Agents Chemother. 1990 Jan;34(1):156–158. doi: 10.1128/aac.34.1.156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  213. Weinstein R. A. Endemic emergence of cephalosporin-resistant Enterobacter: relation to prior therapy. Infect Control. 1986 Feb;7(2 Suppl):120–123. doi: 10.1017/s0195941700065632. [DOI] [PubMed] [Google Scholar]
  214. Weinstein R. A. Epidemiology and control of nosocomial infections in adult intensive care units. Am J Med. 1991 Sep 16;91(3B):179S–184S. doi: 10.1016/0002-9343(91)90366-6. [DOI] [PubMed] [Google Scholar]
  215. Weischer M., Kolmos H. J., Kaufmann M. E., Rosdahl V. T. Biotyping, phage typing, and O-serotyping of clinical isolates of Enterobacter cloacae. APMIS. 1993 Nov;101(11):838–844. doi: 10.1111/j.1699-0463.1993.tb00189.x. [DOI] [PubMed] [Google Scholar]
  216. Weischer M., Kolmos H. J. Retrospective 6-year study of enterobacter bacteraemia in a Danish university hospital. J Hosp Infect. 1992 Jan;20(1):15–24. doi: 10.1016/0195-6701(92)90057-s. [DOI] [PubMed] [Google Scholar]
  217. Weischer M., Kolmos H. J. Ribotyping of selected isolates of Enterobacter cloacae and clinical data related to biotype, phage type, O-serotype, and ribotype. APMIS. 1993 Nov;101(11):879–886. doi: 10.1111/j.1699-0463.1993.tb00196.x. [DOI] [PubMed] [Google Scholar]
  218. Weischer M., Schumacher H., Kolmos H. J. Resistance characteristics of blood culture isolates of Enterobacter cloacae with special reference to beta-lactamases and relation to preceding antimicrobial therapy. APMIS. 1994 May;102(5):356–366. doi: 10.1111/j.1699-0463.1994.tb04884.x. [DOI] [PubMed] [Google Scholar]
  219. Westblom T. U., Coggins M. E. Osteomyelitis caused by Enterobacter taylorae, formerly enteric group 19. J Clin Microbiol. 1987 Dec;25(12):2432–2433. doi: 10.1128/jcm.25.12.2432-2433.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  220. Wiedemann B., Zühlsdorf M. Antibacterial properties of meropenem towards clinical isolates, beta-lactamase producers and laboratory mutants. J Antimicrob Chemother. 1989 Sep;24 (Suppl A):197–205. doi: 10.1093/jac/24.suppl_a.197. [DOI] [PubMed] [Google Scholar]
  221. Willis J., Robinson J. E. Enterobacter sakazakii meningitis in neonates. Pediatr Infect Dis J. 1988 Mar;7(3):196–199. doi: 10.1097/00006454-198803000-00012. [DOI] [PubMed] [Google Scholar]
  222. Wolff M. A., Young C. L., Ramphal R. Antibiotic therapy for enterobacter meningitis: a retrospective review of 13 episodes and review of the literature. Clin Infect Dis. 1993 Jun;16(6):772–777. doi: 10.1093/clind/16.6.772. [DOI] [PubMed] [Google Scholar]
  223. Wüst J., Auckenthaler R., Breer C., Frei R., Heinzer I., Kamm W. Die Antibiotika-Empfindlichkeit von gramnegativen Bakterien auf Intensivpflegestationen in der Schweiz. Schweiz Med Wochenschr. 1994 Oct 1;124(39):1695–1700. [PubMed] [Google Scholar]
  224. Zervos M. J., Kauffman C. A., Therasse P. M., Bergman A. G., Mikesell T. S., Schaberg D. R. Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study. Ann Intern Med. 1987 May;106(5):687–691. doi: 10.7326/0003-4819-106-5-687. [DOI] [PubMed] [Google Scholar]
  225. al Ansari N., McNamara E. B., Cunney R. J., Flynn M. A., Smyth E. G. Experience with Enterobacter bacteraemia in a Dublin teaching hospital. J Hosp Infect. 1994 May;27(1):69–72. doi: 10.1016/0195-6701(94)90070-1. [DOI] [PubMed] [Google Scholar]
  226. de Champs C., Guelon D., Joyon D., Sirot D., Chanal M., Sirot J. Treatment of a meningitis due to an Enterobacter aerogenes producing a derepressed cephalosporinase and a Klebsiella pneumoniae producing an extended-spectrum beta-lactamase. Infection. 1991 May-Jun;19(3):181–183. doi: 10.1007/BF01643247. [DOI] [PubMed] [Google Scholar]
  227. de Champs C., Sirot D., Chanal C., Poupart M. C., Dumas M. P., Sirot J. Concomitant dissemination of three extended-spectrum beta-lactamases among different Enterobacteriaceae isolated in a French hospital. J Antimicrob Chemother. 1991 Apr;27(4):441–457. doi: 10.1093/jac/27.4.441. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES